Synthetic Biology
CRISPR-based Gene Editing Services

CRISPR-based Gene Editing Services

Home / Services / Genetic Engineering and Gene Editing / Genome Editing Service / CRISPR-based Gene Editing Services
CRISPR-based Gene Editing Services

CRISPR-based gene editing services are cutting-edge solutions that leverage the power of CRISPR-Cas9 technology to modify genes in various organisms. By using this powerful and precise gene editing tool, researchers and scientists can make targeted modifications to the DNA sequence with unparalleled accuracy. Our company offers professional CRISPR-based gene editing services to assist researchers in their genetic engineering endeavors, providing them with the expertise and resources needed to drive groundbreaking discoveries and advancements in their respective fields.

Service Process Case Studies FAQs

Service Process

Our CRISPR-based gene editing service process is designed to be efficient and comprehensive, ensuring successful outcomes for our clients. We understand that each research project is unique, and we tailor our approach to meet your specific requirements. The typical workflow of our service process includes the following steps:

  1. Project Consultation: We start by engaging in a thorough discussion to understand your specific research goals and experimental requirements. Our team of experts will work closely with you to design a customized gene editing strategy that aligns with your objectives.
  2. Design and Optimization: Based on the insights gained during the project consultation, we will design the appropriate guide RNA sequences and optimize the CRISPR-Cas9 system for your target gene or genomic region. This step involves careful consideration of factors such as target specificity, efficiency of gene editing, and off-target effects.
  3. Gene Editing Experiment: Our experienced scientists will perform the gene editing experiment using state-of-the-art laboratory techniques and equipment. With a commitment to excellence, we apply rigorous quality control measures to ensure accurate and reliable results. Throughout the experiment, we closely monitor the progress and make adjustments as necessary to achieve the desired gene modifications.
  4. Validation and Analysis: After the gene editing experiment is completed, we meticulously validate the edits and analyze the edited cells or organisms. This may involve various molecular biology assays, such as genotyping, sequencing, or functional characterization, depending on the specific project requirements. By employing cutting-edge technologies and techniques, we ensure the integrity and accuracy of the data obtained.
  5. Data Delivery and Reporting: Once the analysis is complete, we provide you with detailed reports summarizing the experimental results. These reports include comprehensive information about the gene editing outcomes, along with any relevant observations or insights. We understand that interpreting the data is a critical aspect of the research process, and our team is available to assist you in understanding the implications of the findings and discussing potential next steps.

Please feel free to reach out to us with any questions or to discuss your specific research goals and requirements. We look forward to collaborating with you and contributing to the success of your project.

Case Studies

The effect of cas9, targeting-sgRNA, donor DNA and λ-RED in the CRISPR-Cas two-plasmid system. The diagram of the experimental conditions is described in A, of which (a) cas9 was deficient in pCas, (b) targeting sgRNA or (c) donor DNA was deficient in pTargeting series, or in the condition of λ-RED (e) with (RED+) or (d) without induction (RED-). The mutation efficiency is calculated in B. Fraction of spectinomycin-resistant (spec) and kanamycin-resistant (kan), or chloramphenicol-resistant (cm) and kanamycin-resistant (kan) colony-forming units (cfu) calculated from total cfu was calculated under the experiment conditions shown under the histogram and A. Error bars show mean ± s.d. for three independent experiments.

(Y Jiang, et al.,2015)(Y Jiang, et al.,2015)


To address common queries about our CRISPR-based gene editing services, we have compiled a list of frequently asked questions:

Q: How long does the CRISPR-based gene editing process usually take?

A: The timeline for CRISPR-based gene editing services can vary depending on the complexity of the project and the organism involved. During the project consultation phase, we will provide you with an estimated timeline based on your specific requirements.

Q: What are the delivery options for the edited cells or organisms?

A: We offer various delivery options to ensure that you receive the edited cells or organisms in the most convenient and efficient manner. This includes shipment of edited cells or organisms to your laboratory or in vitro functional analysis of the edited cells before delivery.

Q: Is confidentiality ensured for my research project?

A: We understand the importance of confidentiality in scientific research. As such, we prioritize the confidentiality of our clients' research projects. We have strict data protection measures in place, and all project-related information is handled with the utmost care and confidentiality.

Q: Can you assist with downstream applications of gene-edited cells?

A: Absolutely! We have extensive expertise in downstream applications of gene-edited cells, ranging from functional characterization to phenotypic analysis and even in vivo studies. Our team can provide guidance and support for your specific research needs, helping you uncover the full potential of your gene editing experiments.

Q: What are the limitations of CRISPR-based gene editing?

A: While CRISPR-Cas9 is a powerful tool, it has certain limitations. Off-target effects, where unintentional edits occur in non-targeted genomic regions, can occur. Additionally, the delivery of CRISPR components to certain cell types or tissues can be challenging. However, ongoing research and advancements in CRISPR technology aim to address these limitations and improve the precision and efficiency of gene editing.

Q: Can CRISPR-based gene editing be used for therapeutic purposes in humans?

A: CRISPR-based gene editing holds great promise for therapeutic applications in humans. Researchers are actively exploring the potential of CRISPR to treat genetic disorders, develop personalized medicine, and enhance immune therapies. However, significant research, rigorous testing, and regulatory approval are necessary before CRISPR-based therapies can be safely and effectively used in a clinical setting.

Q: How much does CRISPR-based gene editing services cost?

A: The cost of CRISPR-based gene editing services can vary depending on the specific project requirements, including the complexity of the editing, the number of samples, and additional services needed. We provide customized quotes based on your research goals and experimental design. Please reach out to our team for a detailed cost estimate tailored to your project.

Q: Can CRISPR-based gene editing be used in non-model organisms?

A: Yes, CRISPR-based gene editing can be applied to a wide range of organisms beyond traditional model organisms. With the appropriate optimization and design of guide RNA sequences, CRISPR technology can be used to edit the genomes of various organisms, including those with complex genomes or limited genetic tools.

Q: What support do you provide for project troubleshooting?

A: We understand that research projects may encounter challenges along the way. Our team of experts is available to provide guidance and support for troubleshooting any issues that may arise during the CRISPR-based gene editing process. We will work closely with you to identify the problem and explore potential solutions to ensure the success of your project.

Please note that all services are for research use only. Not intended for any clinical use.

Synthetic Biology Services

Online Inquiry